US EditionPublished • loading... • Updated
Novartis, Takeda agree to enter third round of Medicare drug price negotiations
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Novartis, Takeda agree to enter third round of Medicare drug price negotiations
At least two big pharma companies have said they will participate in the upcoming third round of Medicare negotiations under the Inflation Reduction Act, as court challenges against the program persist. Novartis confirmed to ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
